Achieve Life Sciences

This study tested a medicine called cytisinicline to help adults stop vaping. 160 people took either the medicine or a placebo for 12 weeks. The main goal was to see if more people could stay vape-free during the last few weeks of treatment. The medicine aims to reduce cravings a…

This study tested whether adding the drug custirsen to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer live longer. It included 664 adults whose cancer had spread and who had already tried one prior treatment. The main goal was to compare o…

This study looked at the long-term safety of a drug called cytisinicline for helping people quit smoking or vaping. 479 adults who had already been in earlier studies took the drug three times a day for 52 weeks. Researchers tracked serious side effects and other health changes t…

This study tested a pill called cytisinicline in 792 adult smokers who wanted to quit. Participants took the pill or a placebo for either 6 or 12 weeks. The main goal was to see if the pill helped them stop smoking, confirmed by breath tests. The results could offer a new option …

This study tested a pill called cytisinicline to help adults stop smoking. Over 800 daily smokers took either the pill or a placebo for 6 or 12 weeks. The goal was to see if the pill helped them stay smoke-free, verified by breath tests. The study is complete and aims to provide …